Text this: Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer

  _____      ___               _    _     ______  
 |__  //    / _ \\    ____    | || | ||  /_____// 
   / //    | / \ ||  |    \\  | || | ||  `____ `  
  / //__   | \_/ ||  | [] ||  | \\_/ ||  /___//   
 /_____||   \___//   |  __//   \____//   `__ `    
 `-----`    `---`    |_|`-`     `---`    /_//     
                     `-`                 `-`